ITMCTR2200006460尚未招募未知
Clinical Study of Jianpi Yishen Decoction on Intervention of Metabolic Complications of Androgen Deprivation in HSPC Patients
Xiyuan Hospital, Chinese Academy of traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 性别
- Male
入选标准
- •(1) Men aged 45 and over and under 80.
- •(2) HSPC was diagnosed pathologically or clinically.
- •(3) During ADT treatment.
- •1) Prostate cancer stage is t3n0mo, t3n0m1, t3nimo, t3nimi and above.
- •2) Testosterone reached the castration level below 50mg/ml.
- •3) The patient has clinical symptoms of androgen deficiency syndrome: AMS scale score: = 27 points.
- •(4) Serum creatinine = 1.5 × ULN (upper limit of normal range), or calculated creatinine clearance rate of 60ml/min.
- •(5) Liver function serum bilirubin = 1.5 × ULN (except subjects with documented Gilbert syndrome), aspartate aminotransferase (AST) or alanine aminotransferase (ALT) = 2.5 × ULN.
- •(6) The life expectancy is at least 6 months.
- •(7) Subjects whose spouses are women of childbearing age must agree to use double protective contraceptives during the study period and within half a year after the last administration, and must not donate sperm.
- •(8) The subjects (or their legal representatives) sign the informed consent form, indicating that they have understood the purpose of the study and the required procedures, and are willing to participate in the study.
排除标准
- •(1) With serious primary cardiovascular disease, liver disease, kidney disease, hematological disease, lung disease, or serious diseases that affect their survival, such as AIDS, the researchers believe that they should not be selected. Alt, AST and bun of liver function exceed 50% of the upper limit of normal value, and Cr of renal function exceeds the upper limit of normal value, which will not be selected.
- •(2) Active or symptomatic viral hepatitis or chronic liver disease. Consistent infection with human immunodeficiency virus (HIV) and / or hepatitis B virus (detected as positive for hepatitis B surface antigen [hbsag] / or quantitative positive for hepatitis B virus dna[hbv-dna]) or hepatitis C virus (detected as positive for anti hepatitis C virus [hcv] antibody) and / or quantitative positive for hepatitis C virus rna[hcv-rna], and other malignant tumors with a recurrence probability of = 30% in the next 24 months.
- •(3) According to the judgment of the researcher, there are problems that are inconsistent with the best interests of the subjects participating in the study (such as affecting the happiness of the subjects) or that may hinder, restrict or interfere with the relevant evaluation of the research plan. Note: the researcher should ensure that the subjects meet all the inclusion criteria during the screening period.
- •(4) Those who do not meet the inclusion criteria, do not use drugs according to the regulations, and cannot judge the curative effect, or incomplete data affect the judgment of curative effect.
- •(5) Legally disabled patients (blind, deaf, dumb, intellectual disorders), psychotic patients.
研究者
相似试验
招募中
不适用
Clinical Study of Jianpi Yangfei Decoction Combined with Active Breathing and Circulation Technique (ACBT) Training in Treating Elderly Pulmonary InfectioITMCTR2100004984ishui Traditional Chinese Medicine Hospital
尚未招募
3 期
Clinical Study of ''Jieyu Xingyang decoction'' in treating erectile dysfunction caused by antipsychoticErectile dysfunction due to antipsychoticsITMCTR2200005913Affiliated Brain Hospital of Guangzhou Medical University
招募中
1 期
Clinical study on Yixiao Decoction in the treatment of type 2 diabetes complicated with left ventricular diastolic dysfunctioType 2 DiabetesITMCTR2100004708Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
招募中
1 期
Clinical study of jiuwei Yongan Decoction in treating atopic dermatitis (blood deficiency, wind dryness syndrome)Atopic dermatitisITMCTR2000004007Shanghai Changhai Hospital
尚未招募
1 期
Clinical study of Jianpi Jiedu recipe combined with SOX chemotherapy in the first-line treatment of advanced gastric cancerGastric cancerITMCTR2000003833Shuguang hospital affiliated to Shanghai university of traditional Chinese medicine